Oral Drug Delivery Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Description

Global Oral Drug Delivery Market: Overview

Oral drug delivery is the most conducive and favored mode of drug administration attributed to the patient's compliance, flexibility in dosage, least sterility constraints, ease of production, and cost-effectiveness.

Global Oral Drug Delivery Market: Growth Factors

The global oral drug delivery market is expected to witness huge growth owing to the increasing incidences of chronic diseases across the globe. The surge in diseases like autoimmune diseases, rheumatoid arthritis, ulcerative colitis, and many others increased the demand for biologic drugs. The growth and development in the biologics market are further propelling market growth. The increasing penetration of health insurances accelerated market growth. The surge in the emergence of pharmaceutical companies coupled with the reduced cost pressure from the government, patients, and insurers boosts the growth of the global market. One of the major factors responsible for the growth of the global oral drug delivery market is the growing preference of consumers for the less invasive way of drug administration.

However, the reduction in the price of the drugs results in higher uptake of drugs, which in turn increased the profits of the companies. These emerging scenarios are attracting many new entrants and hence positively shaping the trajectory of the global oral drug delivery market.

The reduced price also helped the pharmacy benefit managers, public and private players in the industry. The growing technological developments like gastrointestinal permeation enhancement technology, oral antibody platform, eligen, and others in the drug-making process further fuel the global oral drug delivery market vigorously. The increase in the launch of new products with effective features to treat the patients is paving the way for the development of the sector. The growing adoption of biologic drugs and the introduction of several new platforms are expected to boost market growth. These new platforms are anticipated to develop a technology that will help in optimizing the drug therapeutic value effectively and find a way to enter a drug into a patient's body safely that leads to a positive outcome and better compliance. The improvements in the healthcare sector are contributing significantly to the growth of the global market. The increasing efficacy and safety of the agents from these drugs to target the specific disease further project the market to grow significantly. The growing concentration of the companies on biopharmaceutical products is boosting the market growth significantly.

Global Oral Drug Delivery Market: Segmentation

The global oral drug delivery market can be segmented into type, end-user, and region.

By type, the market can be segmented into taste-making, orodispersible tablets, and controlled release.

By end-user, the market can be segmented into diagnostic centers, ambulatory surgical centers, home care settings, hospitals, and others.

The hospital segment accounts for the largest share in the market owing to a large number of outpatient & inpatient visits and the need for a huge amount of drugs coupled with the delivery devices to fulfill the requirement of a huge patient pool.

Global Oral Drug Delivery Market: Regional analysis

North America holds the largest share in the global oral drug delivery market owing to the significant increase in biologics drugs and the rising prevalence of chronic diseases like diabetes, respiratory allergies, cancer, and many others in the region.

Europe is the leading region in the global market due to increasing extensive research and development activities in the sector.

Asia Pacific is the fastest-growing region with a high CAGR owing to the presence of prominent players and surging demand for personalized medicines in the region.

Global Oral Drug Delivery Market: Competitive Players

Some of the significant players in the global oral drug delivery market are Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Sanofi, Novartis AG, Biocon, Pfizer, Inc., Merrion Pharmaceuticals Plc, Kemwell Biopharma, Catalent Inc, Amgen, Inc., AbbVie, Inc., Merrion Pharmaceuticals Plc, ARx, LLC., Addex Pharma., Enteris BioPharma, Emisphere Technologies, Oramed, SAMYANG BIOPHARMACEUTICAL CORPORATION, Chimerix., Skyepharma Production SAS, Evonik Industries, Unigene Laboratories Inc, F. Hoffmann-La Roche Ltd, Bayer AG, EnteraBio Ltd., AbbVie Inc., and 3M.

Global Oral Drug Delivery Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.

Table Of Content